Zenith Drugs Limited IPO

NSE SME

Listed On: Feb 27, 2024 at ₹ 110.0

₹ 126400 /1600 Shares

Check Allotment

Zenith Drugs Limited IPO Details

19 Feb, 2024

Open Date

22 Feb, 2024

Close Date

23 Feb, 2024

Allotment Date

27 Feb, 2024

Listing Date

Issue Price

₹75-79 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

NSE SME

Registrar

Bigshare Services Pvt Ltd

List Price

110.0

Listing Date

2024-02-27

Market Lot

1600 Shares (₹126,400/-)

Lead Manager

Gretex Corporate Services Limited

Issue Size

5,148,800 shares(aggregating up to ₹40.68 Cr)

Retail Portion

35%

Subscription

179.07 times

IPO Docs

DRHP RHP

Zenith Drugs Limited IPO Subscription Details

As on	QIB / NII	Retail	Total
Shares Offered / Reserved	859,200 / 644,800	1,504,000	3,008,000
Day 1 - 19-02-24 06:00 PM	0.00 / 0.99 x	3.42 x	1.92 x
Day 2 - 20-02-24 06:00 PM	3.53 / 2.50 x	9.41 x	6.25 x
Day 3 - 21-02-24 06:00 PM	3.54 / 7.98 x	19.42 x	12.43 x
Day 4 - 22-02-24 06:00 PM	106.72 / 369.94 x	138.57 x	179.07 x

Zenith Drugs Limited Valuations

EPS Pre IPO

₹4.29/-

EPS Post IPO

₹6.29/-

P/E Pre IPO

18.4

P/E Post IPO

12.56

RoNW

29.88%

Zenith Drugs Limited Company Financials All values are in ₹ Lakh

	31-Mar-23	31-Mar-22	31-Mar-21
Assets	9,793.83	6,858.47	N/A
Revenue	11,569.65	9,266.63	N/A
Profit After Tax	515.29	312.86	N/A

About The Company

Zenith Drugs Limited is a pharmaceutical company specialising in manufacturing and trading high-quality, affordable medicines, including generic drugs.

The company adheres to WHO-GMP guidelines and has received the ISO 9001:2015 certification from a respected EuroUK certification body, demonstrating its commitment to quality.

The product portfolio of the company includes :
ORS Powder;
Liquid Orals;
Ointments;
Liquid Externals; and
Capsules

The Food & Drugs Administration has approved over 600 products, of which 325 are currently in production.

The company is in the process of setting up a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh.

The company supplies its products to countries such as Costa Rica in Central America and the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan , Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.

Zenith Drugs Limited specializes in third-party manufacturing, also known as white label manufacturing, for esteemed pharmaceutical companies such as Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others.

There are currently 89 employees as of March 31, 2023 - 61 on payroll and 28 on contract.

Zenith Drugs Limited - Promoter(s)

Pre Issue Share Holding: 100%

Post Issue Share Holding: 69.68%

Company Promoter(s)

Mr. Sandeep Bhardwaj
Mr. Bhupesh Soni
Mr. Ajay Singh Dassundi

Zenith Drugs Limited IPO - Issue Objectives

Purchase of Machinery & Equipments for Setting up New Unit
Existing Manufacturing Block Upgradation
Working Capital Requirements
General Corporate Purposes.

Zenith Drugs Limited IPO - FAQs

Ans. Zenith Drugs Limited IPO is a SME IPO. The issue is priced at ₹75-79 per equity share. The minimum order quantity is 1600 Shares. The IPO opens on Feb 19, 2024, and closes on Feb 22, 2024. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Ans. The Zenith Drugs Limited IPO opens on Feb 19, 2024 and closes on Feb 22, 2024.

Ans. The size of Zenith Drugs Limited IPO is 5,148,800 shares(aggregating up to ₹40.68 Cr).

Ans. The IPO price band is set between ₹75-79 per equity share.

Ans. To apply for Zenith Drugs Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Zenith Drugs Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Zenith Drugs Limited IPO is Feb 23, 2024.

Ans. The Zenith Drugs Limited IPO will be listed on Feb 27, 2024.

Ans. Follow the steps to check the allotment status for Zenith Drugs Limited IPO here.